Zimbabwe has rejected a significant American healthcare agreement worth $367m (£272m) spanning five years over the United States' demand for sensitive data.
This rejection was revealed after a government memo from December was leaked, indicating that President Emmerson Mnangagwa felt the arrangement was "lopsided".
A government spokesperson later stated that the US was demanding access to genetic material for research and profit but refused to share the benefits from future treatments.
"We will now turn to the challenging and unfortunate process of scaling back our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for further talks to find a deal suitable to all parties so the nation's vital HIV programme can be sustained.
Wider Background
Zimbabwe's decision follows a similar situation in neighbouring Kenya, where a court suspended a related health funding agreement after concerns were filed about the safety of citizens' medical information.
Since returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
USAID had overseen aid for the US government, but Trump stated its spending was "wasteful" and his administration was pursuing direct bilateral agreements to boost transparency and accountability.
As per statements, 16 nations in Africa have to date agreed to these new health pacts, constituting more than $18.3bn in committed funds.
Specifics of the Declined Agreement
The funds for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this collaboration might have yielded immense advantages for Zimbabwean communities, especially the 1.2 million presently receiving HIV treatment via US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, without any corresponding promise of access to any medical innovations – such as new medicines or tests – that could result from that provided information," he stated.
"Put simply, our country would provide the raw materials for scientific discovery without any certainty that the resulting innovations would be accessible to our people should a new health crisis emerge."
National Interest and Global Health
He also noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining systems previously established via the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to deal with potential global health emergencies.
"This mechanism is intended to guarantee that when a country contributes its information, the benefits – including medicines and cures – are shared equitably, not monopolised exclusively by those with the capability to create them."
These objections regarding the US deal "are not meant as opposition to America," he added.
"We are open to ongoing discussions with our American counterparts on how subsequent collaboration could be designed in a manner that respects the independence and interests of each country."
Medical Community Reaction
A leading public health body stated it acknowledged the government's concerns, but suggested that talks must proceed given that a large portion of the nation's HIV programmes relied on foreign aid.
"Where specific concerns exist, such as those relating to data governance or implementation frameworks, these can frequently be resolved via detailed discussion and negotiated safeguards," it added.
The halted deal highlights the complex debate between accepting crucial foreign assistance and safeguarding a country's data in an increasingly interconnected world.